This 60-minute self-paced online tumor board will help pathologists and laboratory professionals, particularly those in community practice, gain deeper scientific knowledge and skills in diagnosing, testing, and treating patients with BRAF-mutant metastatic colorectal cancer (mCRC). Throughout the online tumor board simulation, learners will answer questions designed to help them carefully consider the nuances of each case, building their knowledge and skills related to the detection and optimal management of patients with BRAF-mutant mCRC.
Topics covered include the following:
- NCCN guidelines for conducting biomarker testing, including BRAF testing, for patients with mCRC
- The importance of conducting biomarker testing at the time of diagnosis
- Considerations to optimize fixation and IHC and molecular testing for BRAF mutations in patients with mCRC
- Interpretation and communication of BRAF testing results
- Opportunities for improving turnaround time in molecular testing in mCRC, including current and emerging testing platforms
- Clinicopathologic characteristics of BRAF-mutant mCRC
- New and emerging therapies for patients with BRAF-mutant mCRC
- The importance of effective communication and a team-based approach in the diagnosis and management of patients with mCRC to optimize evidence-based clinical decision-making
Faculty
Wei Jiang, MD, PhD
Associate Professor
Director, Translational Research/Pathology
Shared Resource of Sidney Kimmel Cancer Center
Thomas Jefferson University
Philadelphia,PA
Atrayee Basu-Mallick, MD
Associate Professor
Medical Oncology
Jefferson Health/Jefferson University Hospitals
Philadelphia,PA
The activity offers 1.0 CME/CMLE credit.
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Credit Designation Statement
The ASCP designates this internet activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)â„¢. Physicians should claim only credit commensurate with the extent of their participation in the activity.
ASCP designates this internet activity for a maximum of 1.0 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time
Method of Participation
To complete the activity and receive credit, the participant must complete the online course. CME certificates will be provided online.
This activity is supported by educational grants from Lilly and Pfizer.